Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.41
+0.38 (3.79%)
At close: Jun 17, 2026, 4:00 PM EDT
10.41
-0.01 (-0.05%)
After-hours: Jun 17, 2026, 4:36 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $206.03 million as of June 17, 2026. Its market cap has decreased by -66.07% in one year.
Market Cap
206.03M
Enterprise Value
-59.15M
1-Year Change
-66.07%
Ranking
Category
Stock Price
$10.41
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $206.03M, a decrease of -46.53%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 206.03M | -66.78% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 206.22M |
| Karyopharm Therapeutics | 205.22M |
| LENZ Therapeutics | 204.43M |
| Minerva Neurosciences | 203.59M |
| Arcturus Therapeutics Holdings | 202.94M |
| Compugen | 192.01M |
| Unicycive Therapeutics | 191.44M |
| Outlook Therapeutics | 189.76M |